Medical Marijuana Inc (MJNA)

[Rat Fink]

HUGE! MJNA Q2'17 REVS $6,131,415!!_ MJNA_2016_ANNUAL_REVS_WERE_$8,003,943!!!_https://finance.yahoo.com/news/medical-marijuana-inc-announces-largest-130000160.html

EXCERPT FROM PR AS FOLLOWS:

Medical Marijuana, Inc. Wholly Owned Subsidiary Kannaway Has Largest Sales Month in June Since Company Was Founded

SAN DIEGO, July 11, 2017 /PRNewswire/ – Medical Marijuana, Inc. (MJNA), the first-ever publicly traded cannabis company in the United States, today announced that the second quarter of 2017 generated the largest revenue quarter in the Company's history. Additionally, the Company celebrated the largest-ever single month of revenue in June 2017 as well as the largest sales month and quarter for wholly owned subsidiary Kannaway.

The Company saw a gross revenue increase from $1,660,633 in Q2 2016 to $6,131,415 in Q2 2017, a quarter-over-quarter increase of 269% making it the largest quarter in the Company's history. The Company also saw year-to-date and year-over-year revenue increase from $3,177,103 to $9,651,088 an increase of 203%.

"As a well-known Company of Firsts, we are encouraged to see the Company achieve a new milestone – hitting its highest revenue mark ever in this last financial quarter," said Medical Marijuana, Inc. CEO Dr. Stuart Titus. "We continue to work closely with our portfolio of companies to ensure their success, and look forward to breaking new records as we continue to expand our footprint in new markets."

"We are confident that Kannaway® is on a trajectory that continues to exceed expectations," said Kannaway® CEO Blake Schroeder. "We are proud to be a part of the Medical Marijuana, Inc. family, which actively supports efforts to increase access to cannabidiol (CBD) products worldwide."


"MJNA" REPORTS NET 2016 REVENUE_OF_$8,003,943!!!__http://finance.yahoo.com/news/medical-marijuana-inc-reports-end-130000296.html

EXCERPT FROM PR AS FOLLOWS:

SAN DIEGO, May 2, 2017 /PRNewswire/ -- Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States, today announced financial results for the quarter and year ending December 31, 2016, and provided an overview of recent operational highlights. The Company continued to show strong growth throughout the year, as 2016 revenue increased quarter over quarter by 66% from Q1 to Q4 and Net Comprehensive Income increased to $171,387,975 which is 731% higher than 2015. The company had net revenue of $8,003,943 in 2016.

"As the No. 7 investor in Medical Marijuana, Inc., I'm proud to say we are on course for a historic 2017," Medical Marijuana, Inc. CEO Dr. Stuart Titus said. "From groundbreaking research conducted on the Company's products in Latin America during 2016, to substantial market cap growth by the Company's major investments and the development of new proprietary molecules and IP by portfolio companies, shareholders have a lot to be excited about."

Titus continued, "Medical Marijuana Inc. is a holding company with diversified assets that include nutraceutical sales divisions, as well as investments in early stage pharmaceutical development companies - all in the emerging cannabinoid space. We continue to believe in the future of the botanical as well as the pharmaceutical side - the growth in the Company's net assets in the past year only furthers our belief in our long term strategies to build shareholder value."

Medical Marijuana, Inc. had a positive year of growth in 2016, both with the Company's investments and wholly owned subsidiaries, including international expansion, new patent and trademark filings, sweeping new executive team appointments, new licensing agreements, and unprecedented developments in clinical research -- both for the Company's investment companies and flagship product Real Scientific Hemp Oil™ (RSHO™).

SOURCE: https://www.otcmarkets.com/ajax/showFinancialReportById.pdf?id=169811